المؤلفون: Kintzoglanakis K; Department of Primary Care, Local Health-Team Unit of Thebes, Thebes, Greece., Diamantis C; Department of Primary Care, General Hospital of Livadeia, Livadeia, Greece., Mariolis A; Department of Primary Care, Health Center of Areopolis, Areopolis, Laconia, Greece., Paschou SA; Departement of Endocrinology, Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece.

المصدر: Diabetes & vascular disease research [Diab Vasc Dis Res] 2024 Jul-Aug; Vol. 21 (4), pp. 14791641241269743.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print Cited Medium: Internet ISSN: 1752-8984 (Electronic) Linking ISSN: 14791641 NLM ISO Abbreviation: Diab Vasc Dis Res Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/blood , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Glucagon-Like Peptide-1 Receptor*/agonists , Glucagon-Like Peptide-1 Receptor*/metabolism , Quality of Life* , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/adverse effects , Blood Glucose*/metabolism , Blood Glucose*/drug effects, Humans ; Treatment Outcome ; Risk Factors ; Glycemic Control/adverse effects ; Incretins/therapeutic use ; Incretins/adverse effects ; Biomarkers/blood ; Patient Reported Outcome Measures ; Risk Assessment ; Health Status ; Glucagon-Like Peptide-1 Receptor Agonists

المؤلفون: Kim KS; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Park JS; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Hwang E; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Park MJ; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.; Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin HY; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Lee YH; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Kim KM; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Gautron L; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Godschall E; Department of Biology, University of Virginia, Charlottesville, VA, USA., Portillo B; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Grose K; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Jung SH; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Baek SL; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Yun YH; Department of Anatomy and Cell Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Lee D; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.; Queen Square Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK., Kim E; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea., Ajwani J; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Yoo SH; Department of Forensic Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Seoul, Republic of Korea., Güler AD; Department of Biology, University of Virginia, Charlottesville, VA, USA., Williams KW; Center for Hypothalamic Research, Department of Internal Medicine, Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA., Choi HJ; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.; Department of Anatomy and Cell Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.; Neuroscience Research Institute, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.; Wide River Institute of Immunology, Seoul National University, 101 Dabyeonbat-gil, Hwachon-myeon, Gangwon-do 25159, Republic of Korea.; Department of Brain and Cognitive Sciences, Seoul National University, Seoul, Republic of Korea.

المصدر: Science (New York, N.Y.) [Science] 2024 Jul 26; Vol. 385 (6707), pp. 438-446. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

مواضيع طبية MeSH: Arcuate Nucleus of Hypothalamus*/drug effects , Arcuate Nucleus of Hypothalamus*/metabolism , Dorsomedial Hypothalamic Nucleus*/drug effects , Dorsomedial Hypothalamic Nucleus*/metabolism , Obesity*/drug therapy , Obesity*/psychology , Satiation*/drug effects , Glucagon-Like Peptide-1 Receptor Agonists*/administration & dosage , Glucagon-Like Peptide-1 Receptor Agonists*/pharmacology, Animals ; Female ; Humans ; Male ; Mice ; Agouti-Related Protein/metabolism ; Eating/drug effects ; Feeding Behavior/drug effects ; Glucagon-Like Peptide-1 Receptor/genetics ; Glucagon-Like Peptide-1 Receptor/metabolism ; Mice, Inbred C57BL ; Neurons/drug effects ; Neurons/physiology ; Neuropeptide Y/metabolism ; Optogenetics

المؤلفون: Chan YH; The Cardiovascular Department, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; School of Traditional Chinese Medicine, College of Medicine, Chang-Gung University, Taoyuan City 333, Taiwan.; Microscopy Core Laboratory, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan., Chao TF; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.; Institute of Clinical Medicine, Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan., Chen SW; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City 333, Taiwan., Lee HF; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Division of Cardiology, Department of Medicine, New Taipei City Municipal Tucheng Hospital (Chang Gung Memorial Hospital, Tucheng Branch, Taiwan), New Taipei City 236, Taiwan., Li PR; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan., Yeh YH; The Cardiovascular Department, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan., Kuo CT; The Cardiovascular Department, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan., See LC; Department of Public Health, College of Medicine, Chang Gung University, Taoyuan City 333, Taiwan.; Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University, Taoyuan City 333, Taiwan.; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan City 333, Taiwan., Lip GYH; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool L69 3BX, UK.; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Sep 16; Vol. 109 (10), pp. 2617-2629.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Atrial Fibrillation*/drug therapy , Atrial Fibrillation*/epidemiology , Glucagon-Like Peptide-1 Receptor*/agonists, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Middle Aged ; Taiwan/epidemiology ; Treatment Outcome ; Incidence ; Hypoglycemic Agents/therapeutic use ; Follow-Up Studies ; Heart Failure/epidemiology ; Heart Failure/drug therapy ; Adult ; Glucagon-Like Peptide-1 Receptor Agonists

المؤلفون: Dai M; Zhejiang Chinese Medical University, The Second Clinical Medical College, Zhejiang, China, Dai S; Zhejiang Chinese Medical University, The Second Clinical Medical College, Zhejiang, China, Gu L; Ningbo No. 2 Hospital, Clinic of General Surgery, Zhejiang, China, Xiang Z; Zhejiang Chinese Medical University, The First Clinical Medical College, Zhejiang, China, Xu A; Zhejiang Chinese Medical University, The First Clinical Medical College, Zhejiang, China, Lu S; Zhejiang Chinese Medical University, The Second Clinical Medical College, Zhejiang, China, Yang Y; Zhejiang Chinese Medical University, The Second Clinical Medical College, Zhejiang, China, Zhou C; Ningbo Mingzhou Hospital, Clinic of Endocrinology, Zhejiang, China

المصدر: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2024 Sep 05; Vol. 16 (3), pp. 323-333. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Galenos Yayınevi Country of Publication: Turkey NLM ID: 101519456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1308-5735 (Electronic) NLM ISO Abbreviation: J Clin Res Pediatr Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Randomized Controlled Trials as Topic* , Glucagon-Like Peptide-1 Receptor*/agonists , Hypoglycemic Agents*/therapeutic use , Overweight*/drug therapy , Pediatric Obesity*/drug therapy, Humans ; Adolescent ; Blood Glucose/drug effects ; Exenatide/therapeutic use ; Exenatide/administration & dosage ; Glycated Hemoglobin/drug effects ; Glycated Hemoglobin/metabolism ; Liraglutide/therapeutic use ; Treatment Outcome ; Obesity/drug therapy ; Glucagon-Like Peptide-1 Receptor Agonists

المؤلفون: Samuels JM; Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Niswender KD; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Roumie CL; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville, Tennessee, USA., Spann MD; Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Flynn CR; Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ye F; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Blankush J; Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Irlmeier R; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Funk LM; Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.; Department of Surgery, William S. Middleton Veterans Health Administration Hospital, Madison, Wisconsin, USA., Patel MB; Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville, Tennessee, USA.; Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3906-3913. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptide-1 Receptor*/agonists , Anti-Obesity Agents*/therapeutic use , Anti-Obesity Agents*/adverse effects , Bariatric Surgery*/adverse effects, Humans ; Female ; Middle Aged ; Adult ; Male ; Retrospective Studies ; Young Adult ; Adolescent ; Aged ; Liraglutide/therapeutic use ; Exenatide/therapeutic use ; Obesity, Morbid/surgery ; Glucagon-Like Peptides/therapeutic use ; Glucagon-Like Peptides/analogs & derivatives ; Glucagon-Like Peptides/adverse effects ; Immunoglobulin Fc Fragments/therapeutic use ; Immunoglobulin Fc Fragments/adverse effects ; Recombinant Fusion Proteins/therapeutic use ; Recombinant Fusion Proteins/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists

المؤلفون: Napoli R; Department of Translational Medical Sciences, Unit of Precision Internal Medicine, Federico II University School of Medicine and Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy., Nicolucci A; CORESEARCH, Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy., Larosa M; Medical Affairs, Sanofi S.r.l., Milan, Italy., Rossi MC; CORESEARCH, Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy., Candido R; Diabetes Centre District 3, Azienda Sanitaria Universitaria Integrata, Trieste, Italy.

مؤلفون مشاركون: RESTORE‐G (Retrospective analysis on the therapeutic approaches after GLP‐1 RA treatment in type 2 diabetes patients) Study Group

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3576-3586. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article; Comparative Study; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Hypoglycemic Agents*/therapeutic use , Glycated Hemoglobin*/analysis , Glycated Hemoglobin*/drug effects , Glucagon-Like Peptide-1 Receptor*/agonists , Insulin Glargine*/therapeutic use , Insulin Glargine*/administration & dosage , Insulin, Long-Acting*/therapeutic use, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Blood Glucose/drug effects ; Drug Therapy, Combination ; Italy/epidemiology ; Treatment Outcome ; Comparative Effectiveness Research ; Drug Substitution ; Hypoglycemia/chemically induced ; Glucagon-Like Peptide-1 Receptor Agonists

المؤلفون: Kurian M; NYU Langone Health, New York, New York., Rogers AM; Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania., Peterson RM; UT Health San Antonio, San Antonio, Texas.

المصدر: JAMA [JAMA] 2024 Aug 27; Vol. 332 (8), pp. 672-673.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Obesity Agents*/administration & dosage , Anti-Obesity Agents*/adverse effects , Anti-Obesity Agents*/economics , Bariatric Surgery*/statistics & numerical data , Glucagon-Like Peptide-1 Receptor Agonists*/administration & dosage , Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects , Glucagon-Like Peptide-1 Receptor Agonists*/economics , Obesity*/drug therapy , Obesity*/economics , Obesity*/surgery, Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Health Services Misuse/statistics & numerical data ; Insurance Coverage/economics ; Insurance, Health/economics ; Insurance, Health/statistics & numerical data ; Weight Loss/drug effects

المؤلفون: Gong JY; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia jonathan.shaw@baker.edu.au., Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia jonathan.shaw@baker.edu.au.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 775-776.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Glucagon-Like Peptide-1 Receptor Agonists*/supply & distribution , Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use , Health Care Rationing*/ethics , Health Care Rationing*/statistics & numerical data, Humans ; Glucagon-Like Peptide 1/agonists ; Glucagon-Like Peptide-1 Receptor/agonists ; Receptors, Gastrointestinal Hormone/agonists ; Healthcare Disparities/ethics ; Healthcare Disparities/statistics & numerical data ; Vulnerable Populations/statistics & numerical data

المؤلفون: Persad G; Sturm College of Law, University of Denver, Denver, CO., Dellgren JL; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Emanuel EJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 776.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Glucagon-Like Peptide-1 Receptor Agonists*/supply & distribution , Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use , Health Care Rationing*/ethics , Health Care Rationing*/statistics & numerical data, Humans ; Glucagon-Like Peptide 1/agonists ; Glucagon-Like Peptide-1 Receptor/agonists ; Healthcare Disparities/ethics ; Healthcare Disparities/statistics & numerical data ; Receptors, Gastrointestinal Hormone/agonists ; Vulnerable Populations/statistics & numerical data

المؤلفون: Mensah MO; Yale University, New Haven, CT michael.mensah@yale.edu., Freitas DJ; San Francisco Department of Public Health, San Francisco, CA., Cartwright JR; Alameda Health System, Oakland, CA.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Aug 22; Vol. 391 (8), pp. 775.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Health Care Rationing*/ethics , Health Care Rationing*/statistics & numerical data , Glucagon-Like Peptide-1 Receptor Agonists*/supply & distribution , Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use, Humans ; Glucagon-Like Peptide 1/agonists ; Glucagon-Like Peptide-1 Receptor/agonists ; Healthcare Disparities/ethics ; Healthcare Disparities/statistics & numerical data ; Receptors, Gastrointestinal Hormone/agonists ; Vulnerable Populations/statistics & numerical data